Medical marijuana and the developing role of the pharmacist
- 15 May 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 64 (10) , 1037-1044
Abstract
Purpose. The pharmacology, therapeutic uses, safety, drug–drug interactions, and drug–disease interactions of medical marijuana are reviewed, and the legal issues related to its use and the implications of medical marijuana for the pharmacist are presented.Keywords
This publication has 46 references indexed in Scilit:
- Cannabis use in sickle cell disease: a questionnaire studyBritish Journal of Haematology, 2005
- Cannabis as a precipitant of cardiovascular emergenciesInternational Journal of Cardiology, 2005
- Ataxia and Shaking in a 2-Year-Old GirlPediatric Emergency Care, 2005
- Cannabis-Induced Extrapyramidalism in a Patient on Neuroleptic TreatmentJournal of Clinical Psychopharmacology, 2005
- Cannabis use and the risk of later schizophrenia: a reviewAddiction, 2004
- Marijuana in the management of amyotrophic lateral sclerosisAmerican Journal of Hospice and Palliative Medicine®, 2001
- The Use of Cannabis as a Mood Stabilizer in Bipolar Disorder: Anecdotal Evidence and the Need for Clinical ResearchJournal of Psychoactive Drugs, 1998
- Marijuana for intractable hiccupsThe Lancet, 1998
- Comparison of Bronchial Effects of Nabilone and Terbutaline in Healthy and Asthmatic SubjectsThe Journal of Clinical Pharmacology, 1983
- Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients.Thorax, 1976